The plasma IL-6 levels of the patients with COVID-19 on day 1 and the sepsis patients on days 1 and 2-3, and the plasma amphiregulin levels of the sepsis patients on day 1, were significantly higher than those of the healthy controls (Figure 3A). This evidence concerns the gene IL6 and Sepsis.